Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases.

Casscells SW, Granger E, Kress AM, Linton A, Madjid M, Cottrell L.

Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):108-15. doi: 10.1161/CIRCOUTCOMES.108.820357. Epub 2009 Mar 5.

PMID:
20031822
[PubMed - indexed for MEDLINE]
Free Article
2.

The association between oseltamivir use and adverse neuropsychiatric outcomes among TRICARE beneficiaries, ages 1 through 21 years diagnosed with influenza.

Casscells SW, Granger E, Kress AM, Linton A.

Int J Adolesc Med Health. 2009 Jan-Mar;21(1):79-89.

PMID:
19526698
[PubMed - indexed for MEDLINE]
3.
4.

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.

Smith JR, Sacks S.

Int J Clin Pract. 2009 Apr;63(4):596-605. doi: 10.1111/j.1742-1241.2009.02010.x.

PMID:
19335705
[PubMed - indexed for MEDLINE]
5.

Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.

Orzeck EA, Shi N, Blumentals WA.

Clin Ther. 2007 Oct;29(10):2246-55.

PMID:
18042482
[PubMed - indexed for MEDLINE]
6.

The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons.

Blumentals WA, Song X.

MedGenMed. 2007 Oct 30;9(4):23.

PMID:
18311373
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Health outcomes among patients receiving oseltamivir.

Enger C, Nordstrom BL, Thakrar B, Sacks S, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2004 Apr;13(4):227-37.

PMID:
15255089
[PubMed - indexed for MEDLINE]
8.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
[PubMed - indexed for MEDLINE]
9.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
[PubMed - indexed for MEDLINE]
10.

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D.

Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Review.

PMID:
19026027
[PubMed - indexed for MEDLINE]
11.

Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study.

Nordstrom BL, Oh K, Sacks ST, L'Italien GJ.

Antivir Ther. 2004 Apr;9(2):187-95.

PMID:
15134180
[PubMed - indexed for MEDLINE]
12.

Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza.

Barr CE, Schulman K, Iacuzio D, Bradley JS.

Curr Med Res Opin. 2007 Mar;23(3):523-31.

PMID:
17355734
[PubMed - indexed for MEDLINE]
13.

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F.

Arch Intern Med. 2003 Jul 28;163(14):1667-72.

PMID:
12885681
[PubMed - indexed for MEDLINE]
14.

Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.

Uyeki TM.

Pediatr Infect Dis J. 2003 Feb;22(2):164-77. Review.

PMID:
12586981
[PubMed - indexed for MEDLINE]
15.

Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study.

Devine J, Linton A, Mistry H, Napier J, Trice S, Bacon T.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):891-9. doi: 10.1002/pds.1786.

PMID:
19634117
[PubMed - indexed for MEDLINE]
16.

The effect of zanamivir treatment on influenza complications: a retrospective cohort study.

Cole JA, Loughlin JE, Ajene AN, Rosenberg DM, Cook SE, Walker AM.

Clin Ther. 2002 Nov;24(11):1824-39.

PMID:
12501877
[PubMed - indexed for MEDLINE]
17.

Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir.

Nordstrom BL, Sung I, Suter P, Szneke P.

Curr Med Res Opin. 2005 May;21(5):761-8.

PMID:
15969875
[PubMed - indexed for MEDLINE]
18.

The influence of oseltamivir treatment on the risk of stroke after influenza infection.

Madjid M, Curkendall S, Blumentals WA.

Cardiology. 2009;113(2):98-107. doi: 10.1159/000172796. Epub 2008 Nov 15.

PMID:
19018144
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry.

Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, Aghayev F, Zaman M, Bamgboye E, Dogan N, Coker R, Starzyk K, Dreyer NA, Toovey S.

J Infect Dis. 2010 Oct 15;202(8):1154-60. doi: 10.1086/656316.

PMID:
20831384
[PubMed - indexed for MEDLINE]
Free Article
20.

A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population.

Lin JT, Yu XZ, Cui DJ, Chen XY, Zhu JH, Wang YZ, Wu XD.

Curr Med Res Opin. 2006 Jan;22(1):75-82.

PMID:
16393433
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk